Literature DB >> 17120162

Regulation of phosphorylation of tau by protein kinases in rat brain.

Amitabha Sengupta1, Inge Grundke-Iqbal, Khalid Iqbal.   

Abstract

Microtubule associated protein tau is abnormally hyperphosphorylated in Alzheimer disease (AD) brain. To investigate the role of protein kinases involved in this lesion, metabolically active slices made from brains of adult rats were treated with or without various specific kinase activators in oxygenated artificial cerebrospinal fluid. The basal kinase activities of protein kinase-A (PKA), CaM Kinase II and GSK-3 were stimulated more than two-fold by isoproterenol, bradykinin and wortmannin, respectively. We found that cdk5 activity was co-stimulated with PKA by isoproterenol. Sequential activation of PKA (+cdk5), CaM Kinase II and GSK-3 produced hyperphosphorylation of tau at Ser-198/Ser-199/Ser-202, Ser-214, Thr-231/Ser-235, Ser-262, Ser-396/Ser-404 and Ser-422 sites. Like AD P-tau, the P-tau from brain slices bound to normal tau and its binding to tubulin was inhibited. These studies suggest that PKA, cdk5, CaM Kinase II and GSK-3 are involved in the regulation of phosphorylation of tau and that AD-type phosphorylation of tau is probably a product of the synergistic action of two or more of these kinases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120162     DOI: 10.1007/s11064-006-9205-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

Authors:  Tobias Engel; Félix Hernández; Jesús Avila; José J Lucas
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

2.  Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.

Authors:  Alejandra del C Alonso; Bin Li; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

3.  Detection of tubulin-binding proteins by an overlay assay.

Authors:  L Kremer; J E Domínguez; J Avila
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Phosphorylation affects the ability of tau protein to promote microtubule assembly.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

6.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

7.  New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.

Authors:  D P Hanger; J C Betts; T L Loviny; W P Blackstock; B H Anderton
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

8.  Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases.

Authors:  T J Singh; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-16       Impact factor: 4.124

9.  Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites.

Authors:  W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.

Authors:  Jonathan C Cruz; Huang-Chun Tseng; Joseph A Goldman; Heather Shih; Li-Huei Tsai
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

View more
  17 in total

Review 1.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

Review 2.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

Review 3.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

4.  DOPA Decarboxylase Modulates Tau Toxicity.

Authors:  Rebecca L Kow; Carl Sikkema; Jeanna M Wheeler; Charles W Wilkinson; Brian C Kraemer
Journal:  Biol Psychiatry       Date:  2017-06-15       Impact factor: 13.382

5.  The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.

Authors:  Xiaochuan Wang; Julie Blanchard; Erik Kohlbrenner; Nathalie Clement; R Michael Linden; Aurelian Radu; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  FASEB J       Date:  2010-07-22       Impact factor: 5.191

Review 6.  Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.

Authors:  Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Fei Liu; Cheng-Xin Gong; Inge Grundke-Iqbal
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

Review 7.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

8.  Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1.

Authors:  Miklos Guttman; Gina N Betts; Helen Barnes; Majid Ghassemian; Peter van der Geer; Elizabeth A Komives
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

9.  Phosphorylation controls autoinhibition of cytoplasmic linker protein-170.

Authors:  Ho-Sup Lee; Yulia A Komarova; Elena S Nadezhdina; Rana Anjum; John G Peloquin; Joseph M Schober; Oana Danciu; Jeffrey van Haren; Niels Galjart; Steven P Gygi; Anna Akhmanova; Gary G Borisy
Journal:  Mol Biol Cell       Date:  2010-06-02       Impact factor: 4.138

Review 10.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.